Association of Longitudinal Changes in Cerebral Microstructure with Cognitive Functioning in Breast Cancer Survivors after Adjuvant Chemotherapy

被引:2
|
作者
Chen, Vincent Chin-Hung [1 ,2 ]
Wu, Yi-Fang [3 ]
Tsai, Yuan-Hsiung [1 ,4 ]
Weng, Jun-Cheng [2 ,3 ,5 ]
机构
[1] Chang Gung Univ, Sch Med, Taoyuan 333, Taiwan
[2] Chang Gung Mem Hosp, Dept Psychiat, Chiayi 613, Taiwan
[3] Chang Gung Univ, Dept Med Imaging & Radiol Sci, 259,Wenhua 1st Rd, Taoyuan 333, Taiwan
[4] Chang Gung Mem Hosp, Dept Diagnost Radiol, Chiayi 613, Taiwan
[5] Chang Gung Univ, Dept Artificial Intelligence, Taoyuan 333, Taiwan
关键词
breast cancer; chemotherapy; cognitive impairment; voxel-based morphometry (VBM); vertex-based shape analysis; WHITE-MATTER; CAUDATE-NUCLEUS; GRAY-MATTER; MECHANISMS; WOMEN; IMPAIRMENT; THERAPY; MEMORY; MRI;
D O I
10.3390/jcm13030668
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Adjuvant chemotherapy for breast cancer might impact cognitive function and brain structure. Methods: In this study, we investigated the cerebral microstructural changes in breast cancer survivors after adjuvant chemotherapy and the correlation with cognitive function with both cross-sectional and longitudinal study designs. All participants underwent structural MRI. In total, we recruited 67 prechemotherapy patients (BB), 67 postchemotherapy patients (BA), and 77 healthy controls (BH). For the follow-up study, 28 participants in the BH and 28 in the BB groups returned for imaging and assessment (BHF, BBF). Voxel-based morphometry analysis was performed to evaluate differences in brain volume; vertex-based shape analysis was used to assess the shape alterations of subcortical regions. Moreover, multiple regression was applied to assess the association between the changes in neuropsychological assessment and brain volume. Results: The results showed brain volume reduction in the temporal and parietal gyrus in BB and BA patients. Among each group, we also found significant shape alterations in the caudate and thalamus. Volume reductions in the temporal regions and shape changes in the caudate and hippocampus were also observed in patients from time point 1 to time point 2 (postchemotherapy). An association between brain volume and cognitive performance was also found in the limbic system. Conclusions: Based on our findings, we can provide a better understanding of the cerebral structural changes in breast cancer survivors, establish a subsequent prediction model, and serve as a reference for subsequent treatment.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Cognitive functioning in women following adjuvant treatment for breast cancer
    Rodgers, J
    Morse, R
    Verrill, M
    Kendell, K
    Wesnes, K
    Marshall, I
    Manktelow, TC
    JOURNAL OF PSYCHOPHARMACOLOGY, 2003, 17 (03) : A68 - A68
  • [32] Changes in leukoencephalopathy and serum neurofilament after (neo) adjuvant chemotherapy for breast cancer
    Schroyen, Gwen
    Sleurs, Charlotte
    Ottenbourgs, Tine
    Leenaerts, Nicolas
    Nevelsteen, Ines
    Melis, Michelle
    Smeets, Ann
    Deprez, Sabine
    Sunaert, Stefan
    TRANSLATIONAL ONCOLOGY, 2023, 37
  • [33] THE EFFECT OF ADJUVANT CHEMOTHERAPY ON COGNITIVE FUNCTIONING IN EARLY BREAST CANCER: IMPLICATIONS FOR OUTCOMES RESEARCH AND ONCOLOGY PRACTICE
    Beadle, Geoffrey F.
    Jones, Toni J.
    Kennedy, Katharine J.
    Wright, Margaret J.
    CANCER FORUM, 2006, 34 (01) : 10 - 12
  • [34] Persistent cognitive deficits in breast cancer survivors treated with adjuvant chemotherapy: Neuropsychological and neurophysiological evidence.
    Schagen, S. B.
    Kreukels, B.
    Van Dam, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 482S - 482S
  • [35] Toxicity risk score and clinical decline after adjuvant chemotherapy in older breast cancer survivors
    Ji, Jingran
    Sun, Can-Lan
    Cohen, Harvey J.
    Muss, Hyman B.
    Bae, Marie
    Sedrak, Mina S.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (05): : 578 - 585
  • [36] Clinical and genetic risk factors for bone loss in breast cancer survivors after adjuvant chemotherapy
    Matro, J.
    Stankiewicz, C.
    Horn, M.
    Hwang, W.
    Green, J.
    Su, I.
    Velders, L.
    Sherman, L.
    DeMichele, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [37] Neuropsychological Performance in Survivors of Breast Cancer More Than 20 Years After Adjuvant Chemotherapy
    Koppelmans, Vincent
    Breteler, Monique M. B.
    Boogerd, Willem
    Seynaeve, Caroline
    Gundy, Chad
    Schagen, Sanne B.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (10) : 1080 - 1086
  • [38] Cerebral Hyporesponsiveness and Cognitive Impairment 10 Years After Chemotherapy for Breast Cancer
    de Ruiter, Michiel B.
    Reneman, Liesbeth
    Boogerd, Willem
    Veltman, Dick J.
    van Dam, Frits S. A. M.
    Nederveen, Aart J.
    Boven, Epie
    Schagen, Sanne B.
    HUMAN BRAIN MAPPING, 2011, 32 (08) : 1206 - 1219
  • [39] A longitudinal study on the changes in the self-efficacy of breast cancer patients during adjuvant chemotherapy
    Kuan, Chiao-Chi
    Kuo, Wen-Hung
    Chang, Shu-Hui
    Sun, Huey-Fang
    NURSING OPEN, 2023, 10 (05): : 2912 - 2919
  • [40] ADJUVANT CHEMOTHERAPY OF BREAST-CANCER - LONGITUDINAL-STUDY
    BRACHETTI, AKJ
    EMMRICH, J
    LIMBURG, H
    ARCHIVES OF GYNECOLOGY, 1979, 228 (1-4): : 435 - 436